← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

M

$ Value

$0

Shares

11,250

Price

$0

Filed

Feb 5

Insider

Name

Loerop James

Title

Chief Business Officer

CIK

0001781549

Roles

Officer

Transaction Details

Transaction Date

2026-02-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. | The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2022, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Filing Info

Accession No.

0001781549-26-000009

Form Type

4/A

Issuer CIK

0001557746

Loerop James's History

Date Ticker Type Value
2026-02-03 ACRS M
2026-02-03 ACRS F $21K
2026-02-03 ACRS M $0
2026-02-02 ACRS A $0
2026-02-02 ACRS A $0
2026-02-01 ACRS M
2026-02-01 ACRS M
2026-02-01 ACRS M
2026-02-01 ACRS F $38K
2026-02-01 ACRS M $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02